FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051203262> ?p ?o ?g. }

• W2051203262 abstract "Background: Tumor cells can vary markedly in their response to anti-cancer drugs. Therefore predicting sensitivity or resistance of tumor cells to the drug and developing therapeutic strategies for overcoming the resistance is required to realize personalized medicine for cancer treatment. Although multiple drugs targeting phosphatidylinositol 3-kinase (PI3K) including ZSTK474 are undergoing clinical trials, little is known about the resistance. We previously reported that overexpression of insulin-like growth factor 1 receptor (IGF1R) contributed to acquired resistance to PI3K inhibitors (PI3Kis). In this study, we examined whether IGF1R contributes to intrinsic resistance to PI3Kis and whether combination of IGF1R tyrosine kinase inhibitor (IGF1R-TKI) and PI3Ki is an effective strategy for cancer cells exhibiting the intrinsic resistance to PI3Kis. Materials and Methods: Correlation analyses between the expression level of IGF1R with the efficacy of PI3Ki across an in vitro panel of 39 human cancer cell lines (termed JFCR39) and a panel of 24 human tumor xenografts implanted in nude mice (termed JFCR24 xenografts) were performed. Specific siRNAs against IGF1R were used to examine the functional involvement of IGF1R in intrinsic resistance. Combination effect of ZSTK474 and an IGF1R-TKI OSI-906 was examined in vitro using isobologram analysis and in vivo using human tumor xenografts implanted in nude mice. Results: Correlation analysis revealed that PI3Ki-naive cancer cells expressing high levels of IGF1R exhibited resistance to ZSTK474 in vitro and in vivo. Targeted knockdown of IGF1R expression using specific siRNAs enhanced the efficacy of ZSTK474 in intrinsic resistant cell lines overexpressing IGF1R. In these cell lines, higher concentration of ZSTK474 was needed to dephosphorylate Akt compared to IGF1R-negative cell lines, and specific knockdown of IGF1R made it easier to dephosphorylate Akt after ZSTK474 treatment. Finally, we found a synergistic therapeutic effect of ZSTK474 in combination with OSI-906 in vivo, as well as in vitro. Conclusion: PI3Ki-naive cancer cells overexpressing IGF1R exhibited resistance to ZSTK474, but combination of ZSTK474 with an IGF1R-TKI exerted a remarkable therapeutic response in such cancer cells. We hope that our findings would contribute to personalized medicine using PI3Kis in future clinical application. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):C96. Citation Format: Sho Isoyama, Gensei Kajiwara, Naomi Tamaki, Hisashi Yoshimi, Naoki Nakamura, Mutsumi Okamura, Yumiko Nishimura, Takao Yamori, Shingo Dan. Development of combination therapy with an IGF1R inhibitor and a PI3K inhibitor ZSTK474 in cancer cells exhibiting the intrinsic resistance to PI3K inhibitors. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr C96." @default.
• W2051203262 created "2016-06-24" @default.
• W2051203262 creator A5003695970 @default.
• W2051203262 creator A5004854030 @default.
• W2051203262 creator A5007262286 @default.
• W2051203262 creator A5038117646 @default.
• W2051203262 creator A5046357734 @default.
• W2051203262 creator A5052447311 @default.
• W2051203262 creator A5060700088 @default.
• W2051203262 creator A5081587339 @default.
• W2051203262 creator A5091566693 @default.
• W2051203262 date "2013-11-01" @default.
• W2051203262 modified "2023-09-25" @default.
• W2051203262 title "Abstract C96: Development of combination therapy with an IGF1R inhibitor and a PI3K inhibitor ZSTK474 in cancer cells exhibiting the intrinsic resistance to PI3K inhibitors." @default.
• W2051203262 doi "https://doi.org/10.1158/1535-7163.targ-13-c96" @default.
• W2051203262 hasPublicationYear "2013" @default.
• W2051203262 type Work @default.
• W2051203262 sameAs 2051203262 @default.
• W2051203262 citedByCount "0" @default.
• W2051203262 crossrefType "proceedings-article" @default.
• W2051203262 hasAuthorship W2051203262A5003695970 @default.
• W2051203262 hasAuthorship W2051203262A5004854030 @default.
• W2051203262 hasAuthorship W2051203262A5007262286 @default.
• W2051203262 hasAuthorship W2051203262A5038117646 @default.
• W2051203262 hasAuthorship W2051203262A5046357734 @default.
• W2051203262 hasAuthorship W2051203262A5052447311 @default.
• W2051203262 hasAuthorship W2051203262A5060700088 @default.
• W2051203262 hasAuthorship W2051203262A5081587339 @default.
• W2051203262 hasAuthorship W2051203262A5091566693 @default.
• W2051203262 hasConcept C121608353 @default.
• W2051203262 hasConcept C126322002 @default.
• W2051203262 hasConcept C144174609 @default.
• W2051203262 hasConcept C150903083 @default.
• W2051203262 hasConcept C170493617 @default.
• W2051203262 hasConcept C207001950 @default.
• W2051203262 hasConcept C2775960820 @default.
• W2051203262 hasConcept C502942594 @default.
• W2051203262 hasConcept C62478195 @default.
• W2051203262 hasConcept C71924100 @default.
• W2051203262 hasConcept C86554907 @default.
• W2051203262 hasConcept C86803240 @default.
• W2051203262 hasConcept C95444343 @default.
• W2051203262 hasConcept C96232424 @default.
• W2051203262 hasConcept C98274493 @default.
• W2051203262 hasConceptScore W2051203262C121608353 @default.
• W2051203262 hasConceptScore W2051203262C126322002 @default.
• W2051203262 hasConceptScore W2051203262C144174609 @default.
• W2051203262 hasConceptScore W2051203262C150903083 @default.
• W2051203262 hasConceptScore W2051203262C170493617 @default.
• W2051203262 hasConceptScore W2051203262C207001950 @default.
• W2051203262 hasConceptScore W2051203262C2775960820 @default.
• W2051203262 hasConceptScore W2051203262C502942594 @default.
• W2051203262 hasConceptScore W2051203262C62478195 @default.
• W2051203262 hasConceptScore W2051203262C71924100 @default.
• W2051203262 hasConceptScore W2051203262C86554907 @default.
• W2051203262 hasConceptScore W2051203262C86803240 @default.
• W2051203262 hasConceptScore W2051203262C95444343 @default.
• W2051203262 hasConceptScore W2051203262C96232424 @default.
• W2051203262 hasConceptScore W2051203262C98274493 @default.
• W2051203262 hasLocation W20512032621 @default.
• W2051203262 hasOpenAccess W2051203262 @default.
• W2051203262 hasPrimaryLocation W20512032621 @default.
• W2051203262 hasRelatedWork W1189025943 @default.
• W2051203262 hasRelatedWork W1436721071 @default.
• W2051203262 hasRelatedWork W1514895596 @default.
• W2051203262 hasRelatedWork W1963722416 @default.
• W2051203262 hasRelatedWork W1966093917 @default.
• W2051203262 hasRelatedWork W1971742828 @default.
• W2051203262 hasRelatedWork W1983759482 @default.
• W2051203262 hasRelatedWork W2047774928 @default.
• W2051203262 hasRelatedWork W2079336580 @default.
• W2051203262 hasRelatedWork W2125251091 @default.
• W2051203262 hasRelatedWork W2137993244 @default.
• W2051203262 hasRelatedWork W2151291770 @default.
• W2051203262 hasRelatedWork W2188401602 @default.
• W2051203262 hasRelatedWork W2262820072 @default.
• W2051203262 hasRelatedWork W2337848185 @default.
• W2051203262 hasRelatedWork W2560157215 @default.
• W2051203262 hasRelatedWork W2566186473 @default.
• W2051203262 hasRelatedWork W2887705657 @default.
• W2051203262 hasRelatedWork W2890013245 @default.
• W2051203262 hasRelatedWork W3162141400 @default.
• W2051203262 isParatext "false" @default.
• W2051203262 isRetracted "false" @default.
• W2051203262 magId "2051203262" @default.
• W2051203262 workType "article" @default.